Andrew Saxon, MD

Personal Statement

My area of expertise is addiction psychiatry.

Department Affiliations

Centers/Programs

Recent Publications

Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.
(2020 Mar)
J Subst Abuse Treat 112S(): 41-48
Boudreau DM, Lapham G, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Campbell CI, Rossom RC, Binswanger IA, Yarborough BJ, Arnsten JH, Cunningham CO, Glass JE, Murphy MT, Zare M, Hechter RC, Ahmedani B, Braciszewski JM, Horigian VE, Szapocznik J, Samet JH, Saxon AJ, Schwartz RP, Bradley KA

Potential for Precision Medicine in Methadone Treatment of Opioid Use Disorder.
(2020 Feb 13)
J Addict Med
Saxon AJ

Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder.
(2020 Feb 7)
J Addict Med
Shulman M, Luo S, Campbell ANC, Scodes J, Pavlicova M, Broffman A, Saxon AJ, Nunes EV

Acceptability and Feasibility of a Mobile Health Application for Video Directly Observed Therapy of Buprenorphine for Opioid Use Disorders in an Office-based Setting.
(2020 Jan 14)
J Addict Med
Godersky ME, Klein JW, Merrill JO, Blalock KL, Saxon AJ, Samet JH, Tsui JI

Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.
(2020 Jan 16)
Addict Sci Clin Pract 15(1): 4
Bart GB, Saxon A, Fiellin DA, McNeely J, Muench JP, Shanahan CW, Huntley K, Gore-Langton RE

Show complete publication list »